Career
Other specialties
- Molecular mechanisms of steatotic liver diseases, Gut-Liver-Axis
Career
| Since 07.2025 | Leading Physician, Head of Inpatient Unit |
|---|---|
| 11.2023 – 06.2025 | Attending with extended responsibilities (“Senior physician with extended responsibilities”) |
| 02.2023 | Specialist for Hepatology (FMH) |
| 09.2021 | Venia legendi of University of Zurich (“Privatdozentin”) |
| 09.2020 | Attending (“senior physician”) |
| 06.2020 | FMH Gastroenterology |
| Since 2017 | Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland |
| 08.2015 – 10.2017 | Division of Gastroenterology and Hepatology, University of California San Diego, USA Research fellowship at the laboratory of Prof. Dr. Bernd Schnabl |
| 04.2015 – 07.2015 | FMH General Internal Medicine |
| 06.2012 – 07.2015 | Department of Internal Medicine, Zurich City Hospital Triemli, Switzerland |
| 03.2010 – 05.2012 | Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland |
| 01.2010 | MD Thesis “Transactivation of EGF-Receptor by Angiotensin II in Human Gastric Cancer Cell Lines” |
| 12.2009 | Graduation and Approbation as Physician |
| 2006 – 2009 | Department of Pathology, Charité University Hospital Berlin, Germany |
| 08.2005 – 03.2006 | ERASMUS scholarship for student exchange, Istanbul Üniversitesi, Turkey |
| 2002 – 2009 | Humboldt University of Berlin, Germany |
Most important memberships
- FMH (Swiss Medical Association)
- SASL (Swiss Association for the Study of the Liver)
Research focus
- Gut-barrier defects and NASH
- Complications of chronic liver disease
- Assessment of liver fibrosis